Novel Peptide with Specific Calcium-Binding Capacity from Schizochytrium sp. Protein Hydrolysates and Calcium Bioavailability in Caco-2 Cells

Mar Drugs. 2016 Dec 27;15(1):3. doi: 10.3390/md15010003.

Abstract

Peptide-calcium can probably be a suitable supplement to improve calcium absorption in the human body. In this study, a specific peptide Phe-Tyr (FY) with calcium-binding capacity was purified from Schizochytrium sp. protein hydrolysates through gel filtration chromatography and reversed phase HPLC. The calcium-binding capacity of FY reached 128.77 ± 2.57 μg/mg. Results of ultraviolet spectroscopy, fluorescence spectroscopy, and infrared spectroscopy showed that carboxyl groups, amino groups, and amido groups were the major chelating sites. FY-Ca exhibited excellent thermal stability and solubility, which were beneficial to be absorbed and transported in the basic intestinal tract of the human body. Moreover, the calcium bioavailability in Caco-2 cells showed that FY-Ca could enhance calcium uptake efficiency by more than three times when compared with CaCl₂, and protect calcium ions against dietary inhibitors, such as tannic acid, oxalate, phytate, and Zn2+. Our findings further the progress of algae-based peptide-calcium, suggesting that FY-Ca has the potential to be developed as functionally nutraceutical additives.

Keywords: Schizochytrium sp.; bioavailability; calcium-binding peptide; protein hydrolysate; structure.

MeSH terms

  • Biological Availability
  • Biological Transport / physiology
  • Caco-2 Cells
  • Calcium / metabolism*
  • Cell Line, Tumor
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacology
  • Dietary Supplements
  • Humans
  • Ions / metabolism
  • Peptides / chemistry*
  • Peptides / pharmacokinetics
  • Peptides / pharmacology*
  • Protein Hydrolysates / chemistry*
  • Solubility
  • Stramenopiles / chemistry*

Substances

  • Chelating Agents
  • Ions
  • Peptides
  • Protein Hydrolysates
  • Calcium